Shanghai Hile Bio-Technology Co (SHSE:603718) Beginning Cash Position: ¥124.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603718 Shanghai Hile Bio-Technology Co Ltd SHSE:603718
44 GF Score
Price ¥3.09
GF Value ¥5.88
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Shanghai Hile Bio-Technology Co Beginning Cash Position?

Shanghai Hile Bio-Technology Co SHSE:603718 -0.96% 44 Beginning Cash Position is ¥124.6 Mil as of Jun. 2026. GuruFocus rates SHSE:603718 with a GF Score™ of 44/100 and a GF Value™ of ¥5.88 (Possible Value Trap). The stock has 6 warning signs investors should review.

Shanghai Hile Bio-Technology Co's Beginning Cash Position for the quarter that ended in Jun. 2026 was ¥124.6 Mil.

Shanghai Hile Bio-Technology Co's quarterly Beginning Cash Position declined from Dec. 2025 (¥312.6 Mil) to Mar. 2026 (¥214.3 Mil) and declined from Mar. 2026 (¥214.3 Mil) to Jun. 2026 (¥124.6 Mil).

Shanghai Hile Bio-Technology Co's annual Beginning Cash Position declined from Dec. 2023 (¥160.2 Mil) to Dec. 2024 (¥137.1 Mil) but then increased from Dec. 2024 (¥137.1 Mil) to Dec. 2025 (¥361.2 Mil).

Shanghai Hile Bio-Technology Co Beginning Cash Position Related Terms

Shanghai Hile Bio-Technology Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Shanghai Hile Bio-Technology Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Hile Bio-Technology Co Beginning Cash Position Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.86 153.04 160.20 137.10 361.15

Shanghai Hile Bio-Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 362.24 353.23 312.63 214.31 124.63
SHSE:603718
44GF Score
Shanghai Hile Bio-Technology Co Ltd SHSE:603718
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Hile Bio-Technology Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ¥124.6 Mil mean?
Shanghai Hile Bio-Technology Co (SHSE:603718) has a Beginning Cash Position of ¥124.6 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shanghai Hile Bio-Technology Co and its competitors.
Is Shanghai Hile Bio-Technology Co's Beginning Cash Position too high?
Shanghai Hile Bio-Technology Co's current Beginning Cash Position is ¥124.6 Mil. Overall, Shanghai Hile Bio-Technology Co has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Hile Bio-Technology Co's Beginning Cash Position compare to VRTX and REGN?
Shanghai Hile Bio-Technology Co's Beginning Cash Position of ¥124.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shanghai Hile Bio-Technology Co and its competitors. Shanghai Hile Bio-Technology Co's current Beginning Cash Position is ¥124.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Hile Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co (SHSE:603718) is currently considered Possible Value Trap. The stock's GF Value™ is ¥5.88, compared to a current price of ¥3.09 — trading 47.4% below its estimated fair value. The current Beginning Cash Position is ¥124.6 Mil. Shanghai Hile Bio-Technology Co's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Shanghai Hile Bio-Technology Co (SHSE:603718), the current Beginning Cash Position is ¥124.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Hile Bio-Technology Co (SHSE:603718) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co stock appears to be undervalued. The current stock price of ¥3.09 is trading 47.4% below its estimated GF Value™ of ¥5.88. GuruFocus considers Shanghai Hile Bio-Technology Co to be Possible Value Trap.

Key valuation signals for SHSE:603718:

  • Beginning Cash Position: ¥124.6 Mil
  • GF Value™: ¥5.88 vs. price of ¥3.09 (47.4% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603718 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Hile Bio-Technology Co Business Description

Address No. 138 Huaihai Middle Road, Room 805, Huangpu District, Shanghai, CHN, 200021
Shanghai Hile Bio-Technology Co Ltd is a Chinese biotechnology company focused on the research, development, production, and sale of biological products for human and animal health. Its operations span three main areas: human in vitro diagnostic reagents, animal biological products including vaccines and diagnostic agents for livestock and companion animals, and oral tissue repair and regeneration materials. The company serves hospitals, diagnostic laboratories, veterinary clinics, farms, and dental and medical institutions, primarily across China. Revenue is generated through the sale of its diagnostic reagents, animal biological products, and tissue repair materials, supported by ongoing research and development activities. The company operates within China's growing biopharmaceutical and animal health markets, leveraging its research capabilities to expand its product portfolio across both human and veterinary applications.
44GF Score

Get the complete analysis for SHSE:603718

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.09
Price
¥5.88
GF Value